2023
DOI: 10.25259/sni_222_2023
|View full text |Cite
|
Sign up to set email alerts
|

Multidisciplinary approach to anaplastic and metastatic meningioma: A case report and review of the literature

Abstract: Background: Meningiomas are slow-growing neoplasms, accounting for 20% of all primary intracranial neoplasms and 25% of all intraspinal tumors. Atypical and anaplastic meningiomas are infrequent, representing fewer than 5% of all meningiomas. Unusually, they can show aggressive behavior, and extracranial metastases are extremely rare, representing approximately 0.1% of all reported cases. Case Description: Fifty-six-year-old male patient diagnosed with atypical basal frontal meningioma with multiple resect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 33 publications
(92 reference statements)
0
0
0
Order By: Relevance
“…The standard treatments for anaplastic meningioma are surgical resection and adjuvant radiotherapy [ 1 , 3 , 6 , 8 ]. However, the use of radiotherapy in infants and young children remains a topic of debate due to the increased vulnerability of their central nervous system to potential long-term radiation-related complications [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The standard treatments for anaplastic meningioma are surgical resection and adjuvant radiotherapy [ 1 , 3 , 6 , 8 ]. However, the use of radiotherapy in infants and young children remains a topic of debate due to the increased vulnerability of their central nervous system to potential long-term radiation-related complications [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…Anaplastic meningioma, classified as a WHO grade III, is a rare subtype, accounting for 1%-3% of all meningiomas [ 1 ]. They are highly aggressive with a worse clinical course, including a higher risk of recurrence ranging from 50% to 94%, and increased mortality, with the median survival typically less than 2 years and the 5-year survival ranging from 35% to 61% [ [2] , [3] , [4] ]. Pediatric meningioma, while rare, also presents a worse prognosis compared to adults [ 5 ].…”
Section: Introductionmentioning
confidence: 99%